Technology  June 7, 2021

Reven COO moving to president’s seat

WESTMINSTER — Brian Denomme, co-founder and chief operating officer at Reven Holdings Inc., is taking over the role of president, and a successor has been selected to replace him.

Daniel Hoffman has been selected as the new chief operating officer at Reven, a biotechnology company developing treatments for cancer and viral illnesses such as COVID-19.

“I am incredibly energized to lead the company to its next phase of business development. As part of our company’s continued growth, I am equally excited to work with Dan and help him transition into the role as our new COO,” Denomme said in a prepared statement. “I have tremendous confidence in Dan’s ability to help take Reven to the next level, ensuring best practices and operational excellence across the company.”

SPONSORED CONTENT

Ways to thank a caregiver

If you have a caregiver or know someone who has been serving as a primary caregiver, March 3rd is the day to reach out and show them how much they are valued!

Hoffman’s experience includes a design role with a medical-device firm and a stint as executive creative director for CNBC Business News, according to a Reven news release. 

“As COVID-19 remains at the vanguard impacting everyone’s lives, I’m honored to be a part of a team that is passionate in developing a novel platform drug that will improve people’s lives worldwide and provide a much-needed solution to our most vulnerable patients,” Hoffman said in the release.

Sign up for BizWest Daily Alerts